CDH1 and melanoma: Specifically, Terzuoli et al. (2019) demonstrated that ALDH3A1high non-small-cell lung carcinoma (NSCLC) and melanoma cells exhibited downregulation of E-cadherin compared to ALDH3A1low cells [20].